Biotest Divestiture Trust
CIK 1748876 · last filed 2019-06-07
Biotest Divestiture Trust is a corporate insider who has filed 2 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing shows the insider sold $21.8M of ADMA on Jun 7, 2019. Across all open-market trades the lifetime net is −$21.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $37.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$37.59M
1
2
-$21.80M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADMA | 10%+ Owner | 4,295,580 | $8.75 | $37.59M | -$21.80M | 2 | 2019-06-07 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-07 | ADMA | Sell (S) | −5,813,954 | -$21.80M | EDGAR |
| 2018-08-09 | ADMA | Sell (S) | −8,591,160 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.